GALECTIN THERAPEUTICS INC (GALT) › Net IncomeGALECTIN THERAPEUTICS INC (GALT) — Net IncomeAnnual figures by fiscal year, from SEC filings.2010: -$5.63M2011: -$10.91M2012: -$9.68M2013: -$12.09M2014: -$15.79M2015: -$20.03M2016: -$21.44M2017: -$16.23M2018: -$13.90M2019: -$13.29M2020: -$23.46M2021: -$30.53M2022: -$38.78M2023: -$41.07M2024: -$47.05M2025: -$30.84M-$30.84M2010Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$30.84M+34.5%2024-$47.05M-14.6%2023-$41.07M-5.9%2022-$38.78M-27.0%2021-$30.53M-30.1%2020-$23.46M-76.5%2019-$13.29M+4.4%2018-$13.90M+14.4%2017-$16.23M+24.3%2016-$21.44M-7.0%2015-$20.03M-26.8%2014-$15.79M-30.6%2013-$12.09M-24.9%2012-$9.68M+11.4%2011-$10.91M-93.9%2010-$5.63M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share